| Human tumor virus utilizes exosomes for intercellular communication DG Meckes Jr, KHY Shair, AR Marquitz, CP Kung, RH Edwards, ... Proceedings of the National Academy of Sciences 107 (47), 20370-20375, 2010 | 596 | 2010 |
| An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model M Jennis, CP Kung, S Basu, A Budina-Kolomets, I Julia, J Leu, S Khaku, ... Genes & development 30 (8), 918-930, 2016 | 350 | 2016 |
| Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation CH Yao, R Wang, Y Wang, CP Kung, JD Weber, GJ Patti Elife 8, e41351, 2019 | 314 | 2019 |
| Autophagy in tumor suppression and cancer therapy CP Kung, A Budina, G Balaburski, MK Bergenstock, M Murphy Critical Reviews™ in Eukaryotic Gene Expression 21 (1), 2011 | 229 | 2011 |
| The p53 tumor suppressor in the control of metabolism and ferroptosis K Gnanapradeepan, S Basu, T Barnoud, A Budina-Kolomets, CP Kung, ... Frontiers in endocrinology 9, 124, 2018 | 187 | 2018 |
| Epstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCδ CP Kung, DG Meckes Jr, N Raab-Traub Journal of virology 85 (9), 4399-4408, 2011 | 186 | 2011 |
| The role of the p53 tumor suppressor in metabolism and diabetes CP Kung, ME Murphy The Journal of endocrinology 231 (2), R61, 2016 | 180 | 2016 |
| The P72R polymorphism of p53 predisposes to obesity and metabolic dysfunction CP Kung, I Julia, J Leu, S Basu, S Khaku, F Anokye-Danso, Q Liu, ... Cell reports 14 (10), 2413-2425, 2016 | 114 | 2016 |
| Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3 CP Kung, N Raab-Traub Journal of virology 82 (11), 5486-5493, 2008 | 111 | 2008 |
| Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α S Basu, K Gnanapradeepan, T Barnoud, CP Kung, M Tavecchio, J Scott, ... Genes & development 32 (3-4), 230-243, 2018 | 107 | 2018 |
| The role of RNA editing in cancer development and metabolic disorders CP Kung, LB Maggi Jr, JD Weber Frontiers in Endocrinology 9, 762, 2018 | 99 | 2018 |
| Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer CP Kung, KA Cottrell, S Ryu, ER Bramel, RD Kladney, EA Bao, ... Oncogene 40 (1), 189-202, 2021 | 73 | 2021 |
| It’s getting complicated—a fresh look at p53-MDM2-ARF triangle in tumorigenesis and cancer therapy CP Kung, JD Weber Frontiers in cell and developmental biology 10, 818744, 2022 | 60 | 2022 |
| Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes CP Kung, S Khaku, M Jennis, Y Zhou, ME Murphy Molecular Cancer Research 13 (2), 250-262, 2015 | 60 | 2015 |
| Epstein-Barr virus latent membrane protein 1 modulates distinctive NF-κB pathways through C-terminus-activating region 1 to regulate epidermal growth factor receptor expression CP Kung, N Raab-Traub Journal of virology 84 (13), 6605-6614, 2010 | 60 | 2010 |
| The African-specific S47 polymorphism of p53 alters chemosensitivity S Basu, T Barnoud, CP Kung, M Reiss, ME Murphy Cell cycle 15 (19), 2557-2560, 2016 | 36 | 2016 |
| The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation CP Kung, Q Liu, ME Murphy Cancer Biology & Therapy 18 (7), 484-491, 2017 | 25 | 2017 |
| A link between TP53 polymorphisms and metabolism CP Kung, S Basu, ME Murphy Molecular & cellular oncology 3 (4), e1173769, 2016 | 20 | 2016 |
| Increased mTOR activity and metabolic efficiency in mouse and human cells containing the African-centric tumor-predisposing p53 variant Pro47Ser K Gnanapradeepan, JIJ Leu, S Basu, T Barnoud, M Good, JV Lee, ... Elife 9, e55994, 2020 | 14 | 2020 |
| Tailoring chemotherapy for the African-centric S47 variant of TP53 T Barnoud, A Budina-Kolomets, S Basu, JIJ Leu, M Good, CP Kung, J Liu, ... Cancer research 78 (19), 5694-5705, 2018 | 13 | 2018 |
Jason D. WeberWashington UniversityBestätigte E-Mail-Adresse bei wustl.edu